Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

World-class Biomedical Research Centre to be in West London

11.12.2006
An international team of experts has judged the biomedical research conducted at The Hammersmith Hospitals NHS Trust, St Mary’s NHS Trust and Imperial College London to be amongst the very best in the country.

Health Secretary Patricia Hewitt announced last week (8 December) the creation of eleven Biomedical Research Centres (BRC) and awarded BRC status to the two hospitals in partnership with Imperial College. BRCs will be leaders in translating scientific research into benefits for patients. Imperial’s academic clinicians will work with their NHS colleagues to take research from the bench to the bedside, enabling the adoption of new technologies, techniques and treatments.

The award guarantees the partners research funding of £19.5 million per annum for the next five years, and makes the West London BRC the leading centre for the UK.

Trust Chief Executives Derek Smith and Julian Nettel, and Rector of Imperial College London Sir Richard Sykes said, “We are delighted to be recognised for the innovative research which is carried out through our partnership to advance healthcare and medical research around the world. Our research is at the forefront of biomedical invention with the primary goal of improving patient care.”

Awarding BRC status to the Trusts in academic partnership with Imperial is an endorsement of their intention to become the UK's first Academic Health Science Centre. (AHSC). The AHSC will be a healthcare organisation that integrates governance and management for service delivery, teaching and research, based on tried and tested models around the world. This concept represents a future that has captured the imagination and support of clinical leaders and senior management of all organisations and will enable West London to compete on a global stage.

The AHSC will be a magnet for investment and for clinical leaders who champion the creation and delivery of new diagnostic and treatment options to improve the lives and welfare of patients.

Staff, patients and local communities will be involved in designing and planning the AHSC as well as being formally consulted about it in 2007.

Between them the hospitals can already boast the best breast cancer survival rates; the best lung cancer survival rates; and the third and fourth fewest deaths during coronary artery by-pass operations. They have achieved this record by employing the very latest thinking, technology and treatments.

Imperial College is the UK’s leading clinical academic university with 140 clinical academic fellows and 53 clinical lecturers. It recently had its world-class reputation confirmed by the Times Higher Educational 2006 World University Rankings, which placed the university fourth in the world for biomedicine and ninth in the world overall.

Further endorsement was received in the Chancellor’s pre-budget statement this week (6 December). Gordon Brown announced that the government accepted the findings of a new report into UK Health Research funding, which included a statement of support for the AHSC model. The Cooksey report states: "Universities and Trusts might follow the US Academic Medical Centre model, as Imperial College and St. Mary's and Hammersmith NHS Trusts are doing with their plan to create the UK's first Academic Health Sciences Centre. This proposal, which promises to deliver greater integration of not only research strategies, but vital underpinning human resources and capital assets, should make for a more effective approach to health research and patient care at these institutions.”

Abigail Smith | alfa
Further information:
http://www.imperial.ac.uk

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

Reptile vocalization is surprisingly flexible

30.05.2017 | Life Sciences

EU research project DEMETER strives for innovation in enzyme production technology

30.05.2017 | Power and Electrical Engineering

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>